The FDA issued approvals for Pfizer and Moderna's 2026 COVID-19 vaccines on Thursday, but is recommending them for the same ...

Developing new drugs and therapies is a contact sport for research sites. Investigators are on the frontlines, meeting and ...

Sword Health, a digital therapeutics company that started in the physical therapy space, has acquired digital mental health ...

Pharmaceutical portfolio decision-making is facing structural pressure. Patent expirations, rising development costs, ...

The US FDA has green lit ViiV Healthcare’s Tivicay PD (dolutegravir) for the treatment of HIV-1 in children weighing at least ...

Medical technology company Boston Scientific became the target of a cyberattack this week, which disrupted some of its IT ...

Cambridge, UK-based Neurocrine Biosciences - partnered with Japan’s Nxera Pharma - has announced it has received IND ...

Europe. Whilst long recognised as Europe's largest partnering conference, it's now expanding to become the continent's most ...

The ambition to build a Phase I oncology clinical development centre can be deceptively simple. The temptation is to ...

US President Donald Trump has nominated White House health policy aide Heidi Overton to take up the mantle of commissioner ...

Roche’s Genentech has agreed a deal worth up to $2.3 billion to develop and sell Hanmi Pharmaceutical’s experimental obesity ...

Jazz Pharmaceuticals has been granted US approval for two combinations of its cancer drug Ziihera for people with advanced ...